Delivery Order SPE2DB22D1017-SPE2DB24FF3AV
- Not listed
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $7,792.08, is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The delivery order is part of a larger indefinite delivery contract (IDC) awarded to AmerisourceBergen Drug Corp, valued at up to $999,999,999.00 through December 31, 2025. This IDC serves as the primary...
- This firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a for-profit pharmaceutical company, for the supply of IBRANCE 125 MG TABLET 7S. The award has a total potential value of $7,792.08 and a completion date of March 11, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used for this contract. This delivery order is part of a larger indefinite delivery contract (IDC)...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of the pharmaceutical product IBRANCE 125 MG TABLET 7S, with a completion date of March 5, 2024 and a potential value of $7,792.08. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this order, which is not designated as a set-aside. The company...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $8,118.08 and a performance period ending on July 14, 2025. The contract is not set aside for any specific business type. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the provision of pharmaceuticals, specifically the drug IBRANCE 100 MG TABLET 7S, with a ceiling value of $7,796.30 and an ultimate completion date of April 23, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA Troop Support Medical, valued at up to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product, with a ceiling value of $7,792.08 and an ultimate completion date of October 31, 2024. The contract is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products...
- This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The order is for the provision of 4563753747 IBRANCE 125 MG CAPSULE 21S, with a potential value of $7,792.08 and a completion date of March 15, 2024. This delivery order does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of IBRANCE 125 MG TABLET 7S. The contract has a firm fixed price of $7,792.08 and a completion date of October 9, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the delivery of a...
- This is a $8,122.48 firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of IBRANCE 100 MG TABLET 7S, with a period of performance ending on June 9, 2025. The award was made on May 16, 2025 and does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the supply of IBRANCE 125 MG TABLET 7S, a pharmaceutical product. The contract has a ceiling value of $46,752.48 and a completion date of May 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation for this award. Amerisourcebergen Drug Corp...
- SPE2DB22D1017Indefinite Delivery Contract
- SPE2DB22D1017-SPE2DB24FF3AVDelivery Order
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of IBRANCE 125 MG TABLET 7S, a prescription pharmaceutical product. The contract has a potential value of $7,792.08 and a completion date of March 12, 2024. Amerisourcebergen Drug Corp is the prime contractor on this delivery order and there is no set-aside designation indicated. This delivery order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.8k | 2/20/24 |